Compliance, analgesic use and side-effect protection within a German cohort of the TEAM trial. 2. Juni 2012 Bossart, M., Becker, M., Hadji, P., Kieback, D.G., Hasenburg, A., 2012. Anticancer Res 32, 3933–3938. Abstract Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study. Bartlett, J.M.S., Bloom, K.J., Piper, T., Lawton, T.J., van de Velde, C.J.H., Ross, D.T., Ring, B.Z., Seitz, R.S., Beck, R.A., Hasenburg, A., Kieback, D., Putter,… Weiterlesen Treatment of younger and elderly colorectal cancer patients in German outpatient centres – data from the clinical TKK registry. Freier, W., Groschek, M., Schröder, J., von Verschuer, U., Jänicke, M., Marschner, N., 2012. Onkologie 35 (suppl 6)(P193), 56. doi:10.1159/000170919… Weiterlesen